SBC Medical Group Holdings Incorporated
SBC
$4.08
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -18.35% | -13.65% | -28.76% | 12.28% | 29.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.35% | -13.65% | -28.76% | 12.28% | 29.51% |
| Cost of Revenue | -2.44% | -37.24% | -44.43% | -28.55% | 50.71% |
| Gross Profit | -23.87% | -4.52% | -21.89% | 29.08% | 23.48% |
| SG&A Expenses | 22.79% | -8.33% | -28.88% | 121.05% | -27.61% |
| Depreciation & Amortization | 82.37% | -52.37% | -- | -- | -- |
| Other Operating Expenses | 296.38% | 145.25% | 82.45% | -37.20% | -6.80% |
| Total Operating Expenses | 11.60% | -23.79% | -35.76% | 44.01% | 1.50% |
| Operating Income | -46.67% | -1.06% | -17.56% | -30.91% | 75.27% |
| Income Before Tax | -50.01% | 15.62% | -74.29% | -37.79% | 62.49% |
| Income Tax Expenses | 30.15% | 17.84% | -105.23% | -21.05% | 25.16% |
| Earnings from Continuing Operations | -86.85% | 14.62% | -53.98% | -64.82% | 88.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 125.24% | 40.00% | -107.73% | -100.54% | -108.96% |
| Net Income | -86.70% | 14.63% | -54.41% | -66.10% | 73.25% |
| EBIT | -46.67% | -1.06% | -17.56% | -30.91% | 75.27% |
| EBITDA | -45.98% | -2.55% | -22.00% | -36.28% | 46.67% |
| EPS Basic | -87.92% | 4.57% | -58.24% | -66.40% | -85.38% |
| Normalized Basic EPS | -54.25% | -11.46% | -18.56% | -36.85% | -87.33% |
| EPS Diluted | -87.92% | 4.57% | -18.12% | -66.40% | -85.38% |
| Normalized Diluted EPS | -54.25% | -11.46% | -18.56% | -36.85% | -87.33% |
| Average Basic Shares Outstanding | 9.89% | 9.64% | 9.09% | 0.96% | 1,084.96% |
| Average Diluted Shares Outstanding | 9.89% | 9.64% | 9.09% | 0.96% | 1,084.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |